INS and type 1 diabetes mellitus: For individuals with type 1 diabetes, whose islets have an impaired ability to secrete insulin owing to the autoimmune destruction of their beta cells, exogenous insulin is typically administered preceding mealtimes in anticipation of spikes in blood glucose levels.